Cem Onal, Professor and Chair at Baskent University, shared a post on LinkedIn:
“Excited to share our latest publication!
Our study shows that post-treatment diffusion MRI-derived ADC provides incremental prognostic value following definitive radiotherapy for intermediate- and high-risk prostate cancer, supporting more personalized post-treatment risk stratification.
Sincere thanks to all my co-authors and collaborators for their invaluable contributions and teamwork. Looking forward to future advances in precision radiation oncology.”
Title: Predictive utility of Post-Treatment tumor apparent diffusion coefficient in High-Risk prostate cancer undergoing definitive Radiotherapy: A Long-Term outcome analysis
Authors: Cem Onal, Gurcan Erbay, Ozan Cem Guler, Birhan Demirhan, Aysenur Elmali, Melek Yavuz
Read The Full Article
